BMT CTN BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK Trademark

Trademark Overview


On Tuesday, April 19, 2022, a trademark application was filed for BMT CTN BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK with the United States Patent and Trademark Office. The USPTO has given the BMT CTN BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK trademark a serial number of 97370919. The federal status of this trademark filing is REGISTERED as of Tuesday, February 7, 2023. This trademark is owned by National Marrow Donor Program. The BMT CTN BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting clinical trials for others in the field of blood and bone marrow transplants; Providing medical and scientific research information in the field of clinical trials and blood and bone marrow transplants; Providing a secured-access website that gives blood and bone marrow transplant centers the ability to keep updated on the progress of bone and marrow transplant clinical trials and research
bmt ctn blood & marrow transplant clinical trials network

General Information


Serial Number97370919
Word MarkBMT CTN BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK
Filing DateTuesday, April 19, 2022
Status700 - REGISTERED
Status DateTuesday, February 7, 2023
Registration Number6974453
Registration DateTuesday, February 7, 2023
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements


Description of MarkThe mark consists of the letters "BMT CTN". The words "BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK" appears below. An image of two intertwined semi-circles appear to the left.
Pseudo MarkBMT CTN BLOOD AND MARROW TRANSPLANT CLINICAL TRIALS NETWORK
Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"BMT CTN BLOOD & MARROW TRANSPLANT CLINICAL TRIALS NETWORK"
Goods and ServicesConducting clinical trials for others in the field of blood and bone marrow transplants; Providing medical and scientific research information in the field of clinical trials and blood and bone marrow transplants; Providing a secured-access website that gives blood and bone marrow transplant centers the ability to keep updated on the progress of bone and marrow transplant clinical trials and research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, April 26, 2022
Primary Code042
First Use Anywhere DateMonday, April 18, 2022
First Use In Commerce DateMonday, April 18, 2022

Trademark Owner History


Party NameNational Marrow Donor Program
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressMinneapolis, MN 55401

Party NameNational Marrow Donor Program
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressMinneapolis, MN 55401

Party NameNational Marrow Donor Program
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressMinneapolis, MN 55401

Trademark Events


Event DateEvent Description
Tuesday, February 7, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, February 7, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 28, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 27, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 27, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 2, 2022NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, August 2, 2022EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, August 2, 2022COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Tuesday, August 2, 2022EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Thursday, July 28, 2022ASSIGNED TO EXAMINER
Wednesday, April 27, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, April 26, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 22, 2022NEW APPLICATION ENTERED